
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+20
Genpharm provides fast-track market access to Rare Disease and specialty pharmaceutical companies looking to expand into the Middle East and North Africa (MENA region and Turkey. It is the regional leader in Rare Diseases and the only regional company to have Gene Therapy expertise. Incorporated since 2012, a financially sound and privately owned company, Genpharm is based in the Dubai Science Park (DSP), U.A.E. It also has an office in Boston in the heart of the Biotech hub and in Ireland. Operating through evidence-based medicine and the highest ethical standards, Genpharm provides its partners with fast and sustainable market access...
Pharmaceutical consultancy,pharmaceutical sales,pharmaceutical marketing,market access strategists,pharma consult,pharma services,pharmaceutical sales & marketing,pharma consultancy,orphan drugs,rare disease,genetic disease,middle east,specialty pharmaceuticals,early patient access,name patient sales,reimbursement,gene therapy,neuromuscular diseases,gcc,gene therapy,cell therapy,pharmaceutical market acess ,metabolic and inborn error disease,hematology,and ophtalmology
Genpharm operates in the Marketing services industry.
Genpharm's revenue is 11m - 100m
Genpharm has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.